Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Education

  • Patient Education
  • Scientific Articles
  • Guides & Guidelines
  • Abstract & Posters
  • Reference Materials
  1. Home
  2. Trusted Resources
  3. Education
Oct 18, 2021
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review
Read more
Oct 18, 2021
Mistaken Identity: Using Bone Scintigraphy to Diagnose Cardiac Amyloidosis in Patients With a Monoclonal Gammopathy
Read more
Oct 18, 2021
Monitoring Tafamidis, the Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
Read more
Oct 18, 2021
Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy
Read more
Oct 18, 2021
Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records
Read more
Aug 24, 2021
Natural History and Progression of Transthyretin Amyloid Cardiomyopathy: Insights From ATTR-ACT
Read more
Aug 03, 2021
Current Updates on the Management of AL Amyloidosis
Read more
Aug 03, 2021
Marked Progress in AL Amyloidosis Survival: A 40-Year Longitudinal Natural History Study
Read more
Jul 31, 2021
AL Amyloidosis: Your Essential Guide
Read more
Jun 30, 2021
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Read more

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.

Subscribe

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on